[go: up one dir, main page]

DK0655057T3 - Cyanoguanidiner som kaliumkanalblokkere - Google Patents

Cyanoguanidiner som kaliumkanalblokkere

Info

Publication number
DK0655057T3
DK0655057T3 DK93917262.3T DK93917262T DK0655057T3 DK 0655057 T3 DK0655057 T3 DK 0655057T3 DK 93917262 T DK93917262 T DK 93917262T DK 0655057 T3 DK0655057 T3 DK 0655057T3
Authority
DK
Denmark
Prior art keywords
alkyl
hydrogen
channel blockers
potassium channel
cyanoguanidines
Prior art date
Application number
DK93917262.3T
Other languages
Danish (da)
English (en)
Inventor
Jackson B Hester Jr
Kaushik D Meisheri
Stephen J Humphrey
James H Ludens
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0655057T3 publication Critical patent/DK0655057T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK93917262.3T 1992-08-13 1993-07-21 Cyanoguanidiner som kaliumkanalblokkere DK0655057T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92979592A 1992-08-13 1992-08-13

Publications (1)

Publication Number Publication Date
DK0655057T3 true DK0655057T3 (da) 1998-04-14

Family

ID=25458467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917262.3T DK0655057T3 (da) 1992-08-13 1993-07-21 Cyanoguanidiner som kaliumkanalblokkere

Country Status (16)

Country Link
US (1) US5567722A (es)
EP (1) EP0655057B1 (es)
JP (1) JPH08500111A (es)
CN (1) CN1039997C (es)
AT (1) ATE158279T1 (es)
AU (2) AU4530693A (es)
DE (1) DE69314041T2 (es)
DK (1) DK0655057T3 (es)
ES (1) ES2107049T3 (es)
GR (1) GR3025640T3 (es)
IL (1) IL106641A (es)
MX (1) MX9304882A (es)
MY (1) MY110826A (es)
TW (1) TW223017B (es)
WO (2) WO1994004499A1 (es)
ZA (1) ZA935619B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2116726T3 (es) * 1994-01-28 1998-07-16 Upjohn Co Cianoguanidinas utilizadas como bloqueadores del canal k.
AUPN193095A0 (en) * 1995-03-24 1995-04-27 Polychip Pharmaceuticals Pty Ltd Potassium ion channel blockers
AR008290A1 (es) * 1996-08-15 1999-12-29 Smithkline Beecham Corp Nuevos compuestos que contienen guanidina utiles como antagonistas de los receptores de il-8, composiciones farmaceuticas que los contienenprocedimiento para la preparacion de dichos compuestos y procedimiento para la preparacion de intermediarios.
WO1998006398A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
EP1917244A2 (de) 2005-08-24 2008-05-07 Abbott GmbH & Co. KG Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CN113683535B (zh) * 2020-05-18 2022-08-30 中国药科大学 含氰胍结构的化合物及其制备方法与用途
CN112042664B (zh) * 2020-09-18 2022-06-10 广州古神生物科技有限公司 防霉抗菌剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
NL8000869A (nl) * 1979-02-16 1980-08-19 Eisai Co Ltd Cyanoguanidine-derivaten en werkwijze voor de bereiding daarvan.
JPH01166119A (ja) * 1987-12-23 1989-06-30 Hitachi Ltd データ入力装置の制御方式
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
AU623217B2 (en) * 1989-02-03 1992-05-07 Eli Lilly And Company (-)-n"-cyano-n-3-pyridyl-n'-1,2,2-trimethyl- propylguanidine, a process for preparing the compound, and use of the compound as a medicament
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers

Also Published As

Publication number Publication date
JPH08500111A (ja) 1996-01-09
EP0655057B1 (en) 1997-09-17
WO1994004499A1 (en) 1994-03-03
DE69314041D1 (de) 1997-10-23
ES2107049T3 (es) 1997-11-16
ZA935619B (en) 1995-02-03
US5567722A (en) 1996-10-22
CN1039997C (zh) 1998-09-30
AU4530693A (en) 1994-03-15
DE69314041T2 (de) 1998-02-05
IL106641A0 (en) 1993-12-08
EP0655057A1 (en) 1995-05-31
TW223017B (es) 1994-05-01
ATE158279T1 (de) 1997-10-15
IL106641A (en) 2001-01-11
WO1994004500A1 (en) 1994-03-03
CN1090575A (zh) 1994-08-10
MX9304882A (es) 1994-07-29
GR3025640T3 (en) 1998-03-31
MY110826A (en) 1999-05-31
AU4683193A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
NO20013379D0 (no) 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler
CL2004001167A1 (es) Compuestos derivados de tiazolidindionas; procedimiento de elaboracion: composicion farmaceutica que los contiene; y su uso en el tratamiento de la diabetes.
DK1113011T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
DK0655057T3 (da) Cyanoguanidiner som kaliumkanalblokkere
AU7615794A (en) Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
FI812804L (fi) 2-(1,4-bensodioxan-2-ylalkyl)-imidazoler anvaendbara som antidepressiva laekemedel
ES2093091T3 (es) Derivado de glutation.
DK0703904T3 (da) Pyrimidin-cyanoguanidiner som K-kanalblokkere
MY131544A (en) Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
ES2152319T3 (es) Derivado del benceno util contra isquemias.
ATE166343T1 (de) Cyanoguanidine als k-kanal-blocker
DK1049672T3 (da) Azetidincarboxamid-derivater til behandling af CNS-lidelser
MX9305918A (es) Derivados de n-(2-amino-2-oxoetil)butanodiamida inhibidores de la renina procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
FI935690A0 (fi) Oralt aktiva antivirala foereningar
NO922523L (no) Aminopyrimidinkarboksamiddrivater med terapeutisk virkning
DK0698601T3 (da) Fremgangsmåde til fremstilling af (-)-N-methyl-N-4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorphenyl)butylbenzami
SE7713864L (sv) Nortropinkarbazatderivat och forfarande for framstellning av dem
TH14335A (th) ไซแอโนกัวนิดีนเป็นตัวสกัดกั้นช่องผ่านออกของโพแทสเซียม
TH9062B (th) ไซแอโนกัวนิดีนเป็นตัวสกัดกั้นช่องผ่านออกของโพแทสเซียม